HEADER HORMONE RECEPTOR/PEPTIDE 19-MAY-11 2YJA TITLE STAPLED PEPTIDES BINDING TO ESTROGEN RECEPTOR ALPHA. COMPND MOL_ID: 1; COMPND 2 MOLECULE: STAPLED PEPTIDE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ESTROGEN RECEPTOR; COMPND 7 CHAIN: B; COMPND 8 FRAGMENT: LIGAND-BINDING DOMAIN, RESIDUES 299-551; COMPND 9 SYNONYM: ER, ER-ALPHA, ESTRADIOL RECEPTOR, NUCLEAR RECEPTOR SUBFAMILY COMPND 10 3 GROUP A MEMBER 1; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 11 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HORMONE RECEPTOR-PEPTIDE COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.PHILLIPS,L.R.ROBERTS,M.SCHADE,R.BAZIN,A.BENT,N.L.DAVIES,S.L.IRVING, AUTHOR 2 R.MOORE,A.D.PANNIFER,D.G.BROWN,A.R.PICKFORD,A.SCOTT,B.XU REVDAT 2 13-NOV-24 2YJA 1 REMARK LINK REVDAT 1 03-AUG-11 2YJA 0 JRNL AUTH C.PHILLIPS,L.R.ROBERTS,M.SCHADE,R.BAZIN,A.BENT,N.L.DAVIES, JRNL AUTH 2 R.MOORE,A.D.PANNIFER,A.R.PICKFORD,S.H.PRIOR,C.M.READ, JRNL AUTH 3 A.SCOTT,D.G.BROWN,B.XU,S.L.IRVING JRNL TITL DESIGN AND STRUCTURE OF STAPLED PEPTIDES BINDING TO ESTROGEN JRNL TITL 2 RECEPTORS. JRNL REF J.AM.CHEM.SOC. V. 133 9696 2011 JRNL REFN ISSN 0002-7863 JRNL PMID 21612236 JRNL DOI 10.1021/JA202946K REMARK 2 REMARK 2 RESOLUTION. 1.82 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.9.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.82 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.60 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 3 NUMBER OF REFLECTIONS : 23603 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1188 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.82 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.90 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.71 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2294 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2104 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2181 REMARK 3 BIN R VALUE (WORKING SET) : 0.2077 REMARK 3 BIN FREE R VALUE : 0.2620 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.93 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 113 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2054 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 124 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.84 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.42 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.88830 REMARK 3 B22 (A**2) : -2.12690 REMARK 3 B33 (A**2) : 0.23870 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.200 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.144 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.133 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.140 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.132 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.911 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2116 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2866 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 721 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 65 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 309 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2116 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 273 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2650 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.72 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 22.33 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL-DIST CONTACT TERM CONTACT SETUP. REMARK 3 ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY. REMARK 4 REMARK 4 2YJA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-MAY-11. REMARK 100 THE DEPOSITION ID IS D_1290048339. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23603 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 32.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 32.59600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 32.59600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 37.51600 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.20350 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 37.51600 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.20350 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 32.59600 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 37.51600 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 55.20350 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 32.59600 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 37.51600 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 55.20350 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6300 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21850 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 75.03200 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 32.59600 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B 297 REMARK 465 SER B 298 REMARK 465 LYS B 299 REMARK 465 ARG B 300 REMARK 465 SER B 301 REMARK 465 LYS B 302 REMARK 465 LYS B 303 REMARK 465 ASN B 304 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU B 549 O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B 332 76.70 39.97 REMARK 500 LEU B 462 -146.10 -78.24 REMARK 500 SER B 464 65.62 -26.29 REMARK 500 THR B 465 -155.15 51.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EST B 1550 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2YAT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ESTRADIOL DERIVED METAL CHELATE AND ESTROGEN REMARK 900 RECEPTOR-LIGAND BINDING DOMAIN COMPLEX REMARK 900 RELATED ID: 1XP1 RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 COMPOUND 15 REMARK 900 RELATED ID: 1QKT RELATED DB: PDB REMARK 900 RELATED ID: 1R5K RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 GW5638 REMARK 900 RELATED ID: 1ZKY RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 OBCP-3M AND A GLUCOCORTICOID RECEPTORINTERACTING PROTEIN 1 NR BOX REMARK 900 II PEPTIDE REMARK 900 RELATED ID: 2BJ4 RELATED DB: PDB REMARK 900 ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE- DISPLAY REMARK 900 DERIVED PEPTIDE ANTAGONIST REMARK 900 RELATED ID: 1AKF RELATED DB: PDB REMARK 900 HOMOLOGOUS-EXTENSION-BASED MODEL OF HUMAN ESTROGEN RECEPTOR WITH REMARK 900 BOUND ESTRADIOL, THEORETICAL MODEL REMARK 900 RELATED ID: 1HCP RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: HUMAN/CHICKEN ESTROGEN RECEPTOR; CHAIN: NULL; REMARK 900 DOMAIN: DEOXYRIBONUCLEIC ACID-BINDING DOMAIN (ERDBD); ENGINEERED: REMARK 900 YES REMARK 900 RELATED ID: 1HCQ RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: HUMAN/CHICKEN ESTROGEN RECEPTOR; CHAIN: A, B, REMARK 900 E, F; DOMAIN: DEOXYRIBONUCLEIC ACID- BINDING DOMAIN (ERDBD); REMARK 900 ENGINEERED: YES; MOL_ID: 2; MOLECULE: DEOXYRIBONUCLEIC ACID (5'-D( REMARK 900 CPCPAPGPGPTPCPAPCPAPGPTPGP APCPCPTPG)-3') (DOT) DEOXYRIBONUCLEIC REMARK 900 ACID (5'-D(CPCPAPGPGPTPCPA PCPTPGPTPGPAPCPCPTPG)-3'); CHAIN: C, D, REMARK 900 G, H REMARK 900 RELATED ID: 1A52 RELATED DB: PDB REMARK 900 ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO ESTRADIOL REMARK 900 RELATED ID: 1QKU RELATED DB: PDB REMARK 900 RELATED ID: 1G50 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A WILD TYPE HER ALPHA LBD AT 2.9ANGSTROM REMARK 900 RESOLUTION REMARK 900 RELATED ID: 1XP6 RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 COMPOUND 16 REMARK 900 RELATED ID: 1PCG RELATED DB: PDB REMARK 900 HELIX-STABILIZED CYCLIC PEPTIDES AS SELECTIVE INHIBITORS OFSTEROID REMARK 900 RECEPTOR-COACTIVATOR INTERACTIONS REMARK 900 RELATED ID: 2B1V RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 OBCP-1M AND A GLUCOCORTICOID RECEPTORINTERACTING PROTEIN 1 NR BOX REMARK 900 II PEPTIDE REMARK 900 RELATED ID: 2JF9 RELATED DB: PDB REMARK 900 ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC REMARK 900 PEPTIDE ANTAGONIST REMARK 900 RELATED ID: 1UOM RELATED DB: PDB REMARK 900 THE STRUCTURE OF ESTROGEN RECEPTOR IN COMPLEX WITH A SELECTIVE AND REMARK 900 POTENT TETRAHYDROISOCHIOLIN LIGAND. REMARK 900 RELATED ID: 1YIM RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 COMPOUND 4 REMARK 900 RELATED ID: 2AYR RELATED DB: PDB REMARK 900 A SERM DESIGNED FOR THE TREATMENT OF UTERINE LEIOMYOMA WITHUNIQUE REMARK 900 TISSUE SPECIFICITY FOR UTERUS AND OVARIES IN RATS REMARK 900 RELATED ID: 3ERT RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 4-HYDROXYTAMOXIFEN REMARK 900 RELATED ID: 1YIN RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 COMPOUND 3F REMARK 900 RELATED ID: 1ERR RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 RALOXIFENE REMARK 900 RELATED ID: 1X7R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITHGENISTEIN REMARK 900 RELATED ID: 3ERD RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 DIETHYLSTILBESTROL AND A GLUCOCORTICOIDRECEPTOR INTERACTING PROTEIN REMARK 900 1 NR BOX II PEPTIDE REMARK 900 RELATED ID: 1L2I RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 (R,R)-5,11-CIS-DIETHYL-5,6,11,12 -TETRAHYDROCHRYSENE-2,8-DIOL AND A REMARK 900 GLUCOCORTICOID RECEPTORINTERACTING PROTEIN 1 NR BOX II PEPTIDE REMARK 900 RELATED ID: 1XP9 RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 COMPOUND 18 REMARK 900 RELATED ID: 2FAI RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 OBCP-2M AND A GLUCOCORTICOID RECEPTORINTERACTING PROTEIN 1 NR BOX REMARK 900 II PEPTIDE REMARK 900 RELATED ID: 1GWR RELATED DB: PDB REMARK 900 HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX REMARK 900 WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE REMARK 900 RELATED ID: 1SJ0 RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 THE ANTAGONIST LIGAND 4-D REMARK 900 RELATED ID: 2JFA RELATED DB: PDB REMARK 900 ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH AN AFFINITY-SELECTED REMARK 900 COREPRESSOR PEPTIDE REMARK 900 RELATED ID: 1GWQ RELATED DB: PDB REMARK 900 HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX REMARK 900 WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE REMARK 900 RELATED ID: 1XPC RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 COMPOUND 19 REMARK 900 RELATED ID: 1X7E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITHWAY-244 REMARK 900 RELATED ID: 1XQC RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF ERALPHA LBD BOUND TO ATETRAHYDROISOQUINOLINE REMARK 900 SERM LIGAND AT 2.05A RESOLUTION REMARK 900 RELATED ID: 1ERE RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 17BETA-ESTRADIOL REMARK 900 RELATED ID: 2YJD RELATED DB: PDB REMARK 900 STAPLED PEPTIDE BOUND TO ESTROGEN RECEPTOR BETA REMARK 900 RELATED ID: 2LDD RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE ESTROGEN RECEPTOR-BINDING STAPLED PEPTIDE REMARK 900 SP6 (AC-EKHKILXRLLXDS-NH2) REMARK 900 RELATED ID: 2LDA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE ESTROGEN RECEPTOR-BINDING STAPLED PEPTIDE REMARK 900 SP2 (AC-HKXLHQXLQDS-NH2) REMARK 900 RELATED ID: 2LDC RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE ESTROGEN RECEPTOR-BINDING STAPLED PEPTIDE REMARK 900 SP1 (AC-HXILHXLLQDS-NH2) DBREF 2YJA A 0 12 PDB 2YJA 2YJA 0 12 DBREF 2YJA B 299 551 UNP P03372 ESR1_HUMAN 299 551 SEQADV 2YJA GLY B 297 UNP P03372 EXPRESSION TAG SEQADV 2YJA SER B 298 UNP P03372 EXPRESSION TAG SEQRES 1 A 13 ACE HIS LYS MK8 LEU HIS GLN MK8 LEU GLN ASP SER NH2 SEQRES 1 B 255 GLY SER LYS ARG SER LYS LYS ASN SER LEU ALA LEU SER SEQRES 2 B 255 LEU THR ALA ASP GLN MET VAL SER ALA LEU LEU ASP ALA SEQRES 3 B 255 GLU PRO PRO ILE LEU TYR SER GLU TYR ASP PRO THR ARG SEQRES 4 B 255 PRO PHE SER GLU ALA SER MET MET GLY LEU LEU THR ASN SEQRES 5 B 255 LEU ALA ASP ARG GLU LEU VAL HIS MET ILE ASN TRP ALA SEQRES 6 B 255 LYS ARG VAL PRO GLY PHE VAL ASP LEU THR LEU HIS ASP SEQRES 7 B 255 GLN VAL HIS LEU LEU GLU CYS ALA TRP LEU GLU ILE LEU SEQRES 8 B 255 MET ILE GLY LEU VAL TRP ARG SER MET GLU HIS PRO GLY SEQRES 9 B 255 LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP ARG ASN SEQRES 10 B 255 GLN GLY LYS CYS VAL GLU GLY MET VAL GLU ILE PHE ASP SEQRES 11 B 255 MET LEU LEU ALA THR SER SER ARG PHE ARG MET MET ASN SEQRES 12 B 255 LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SER ILE ILE SEQRES 13 B 255 LEU LEU ASN SER GLY VAL TYR THR PHE LEU SER SER THR SEQRES 14 B 255 LEU LYS SER LEU GLU GLU LYS ASP HIS ILE HIS ARG VAL SEQRES 15 B 255 LEU ASP LYS ILE THR ASP THR LEU ILE HIS LEU MET ALA SEQRES 16 B 255 LYS ALA GLY LEU THR LEU GLN GLN GLN HIS GLN ARG LEU SEQRES 17 B 255 ALA GLN LEU LEU LEU ILE LEU SER HIS ILE ARG HIS MET SEQRES 18 B 255 SER ASN LYS GLY MET GLU HIS LEU TYR SER MET LYS CYS SEQRES 19 B 255 LYS ASN VAL VAL PRO LEU TYR ASP LEU LEU LEU GLU MET SEQRES 20 B 255 LEU ASP ALA HIS ARG LEU HIS ALA MODRES 2YJA MK8 A 3 LEU 2-METHYL-L-NORLEUCINE MODRES 2YJA MK8 A 7 LEU 2-METHYL-L-NORLEUCINE HET ACE A 0 3 HET MK8 A 3 9 HET MK8 A 7 9 HET NH2 A 12 1 HET EST B1550 20 HETNAM ACE ACETYL GROUP HETNAM MK8 2-METHYL-L-NORLEUCINE HETNAM NH2 AMINO GROUP HETNAM EST ESTRADIOL FORMUL 1 ACE C2 H4 O FORMUL 1 MK8 2(C7 H15 N O2) FORMUL 1 NH2 H2 N FORMUL 3 EST C18 H24 O2 FORMUL 4 HOH *124(H2 O) HELIX 1 1 LYS A 2 ASP A 10 1 9 HELIX 2 2 LEU B 306 LEU B 310 5 5 HELIX 3 3 THR B 311 ALA B 322 1 12 HELIX 4 4 SER B 338 VAL B 364 1 27 HELIX 5 5 GLY B 366 LEU B 370 5 5 HELIX 6 6 THR B 371 SER B 395 1 25 HELIX 7 7 ARG B 412 LYS B 416 1 5 HELIX 8 8 GLY B 420 MET B 438 1 19 HELIX 9 9 GLN B 441 SER B 456 1 16 HELIX 10 10 SER B 464 ALA B 493 1 30 HELIX 11 11 THR B 496 LYS B 531 1 36 HELIX 12 12 TYR B 537 ALA B 546 1 10 SHEET 1 BA 2 LYS B 401 ALA B 405 0 SHEET 2 BA 2 LEU B 408 ASP B 411 -1 O LEU B 408 N PHE B 404 LINK C ACE A 0 N HIS A 1 1555 1555 1.38 LINK C LYS A 2 N MK8 A 3 1555 1555 1.38 LINK C MK8 A 3 N LEU A 4 1555 1555 1.39 LINK CE MK8 A 3 CE MK8 A 7 1555 1555 1.30 LINK C GLN A 6 N MK8 A 7 1555 1555 1.37 LINK C MK8 A 7 N LEU A 8 1555 1555 1.37 LINK C SER A 11 N NH2 A 12 1555 1555 1.36 CISPEP 1 ARG B 335 PRO B 336 0 1.00 SITE 1 AC1 10 MET B 343 LEU B 346 GLU B 353 LEU B 387 SITE 2 AC1 10 ARG B 394 PHE B 404 MET B 421 HIS B 524 SITE 3 AC1 10 LEU B 525 HOH B2025 CRYST1 75.032 110.407 65.192 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013328 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009057 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015339 0.00000 HETATM 1 C ACE A 0 39.454 6.254 -6.975 1.00 81.67 C HETATM 2 O ACE A 0 39.944 7.015 -7.795 1.00 82.21 O HETATM 3 CH3 ACE A 0 39.794 4.787 -7.069 1.00 82.07 C